Tigermed Consulting, a CRO based in Shanghai, received $5 million in venture capital from Qiming Venture Partners of Shanghai and Seattle. Tigermed offers out-sourced R&D, including clinical trials (with an emphasis on new chemical entities), biological statistics, medical translation services, and registration services. Established in 2004, Tigermed’s main offices are in Beijing, Shanghai and Hangzhou, and it counts a total of 11 offices in China. More details...